[{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Isomaltulose","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"German Sport University, Cologne","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Low Glycaemic Index","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ German Sport University, Cologne","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ German Sport University, Cologne"},{"orgOrder":0,"company":"Beneo","sponsor":"Universitair Ziekenhuis Brussel","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"New Prebiotic Follow-On Formula","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Universitair Ziekenhuis Brussel","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Universitair Ziekenhuis Brussel"},{"orgOrder":0,"company":"Beneo","sponsor":"Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Prebiotic","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili"},{"orgOrder":0,"company":"Beneo","sponsor":"University of Reading","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Prebiotic","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ University of Reading","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ University of Reading"},{"orgOrder":0,"company":"Beneo","sponsor":"Daacro","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"GERMANY","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Prebiotic Fiber","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Daacro","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Daacro"},{"orgOrder":0,"company":"Beneo","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Vitalose","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ BioTeSys GmbH"}]

Find Clinical Drug Pipeline Developments & Deals by Beneo

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Prebiotic Fiber is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress Disorders, Traumatic.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          July 10, 2025

                          Lead Product(s) : Prebiotic Fiber

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Daacro

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Low Glycaemic Index is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 30, 2023

                          Lead Product(s) : Low Glycaemic Index

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : German Sport University, Cologne

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Lead Product(s) : New Prebiotic Follow-On Formula

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : Universitair Ziekenhuis Brussel

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : New Prebiotic Follow-On Formula is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 24, 2023

                          Lead Product(s) : New Prebiotic Follow-On Formula

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Universitair Ziekenhuis Brussel

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Isomaltulose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 29, 2022

                          Lead Product(s) : Isomaltulose

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Swansea University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          January 28, 2022

                          Lead Product(s) : Prebiotic

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : University of Reading

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Lead Product(s) : Prebiotic

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 10, 2021

                          Lead Product(s) : Prebiotic

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Vitalose is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 22, 2020

                          Lead Product(s) : Vitalose

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : BioTeSys GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank